AdvanSix (NYSE: ASIX) reported Q4 EPS of $0.80, $0.01 worse than the analyst estimate of $0.81. Revenue for the quarter came in at $424.1 million versus the consensus estimate of $408.3 million.

Outlook:

• Targeting significant earnings growth in 2022 supported by expected strong execution and robust ammonium sulfate fertilizer performance
• Expect strong North America demand for nylon and chemical intermediates to continue
• Successful integration of U.S. Amines expected to deliver year one earnings accretion
• Continue to expect Capital Expenditures to be $95 to $105 million in 2022 reflecting scope of planned plant turnarounds and timing of project execution
• Expect pre-tax income impact of planned plant turnarounds to be approximately $33 to $38 million in 2022

"2022 is shaping up to be another exciting year for AdvanSix. We are targeting significant earnings growth as we continue to execute on our strategic priorities including superior operational excellence, differentiated product growth and being strong and disciplined stewards of capital. Demand is expected to remain strong across our nylon and chemical intermediates product lines and we are in the midst of the strongest fertilizer environment that we've seen in over a decade. We are gaining momentum for our next chapter and remain confident that AdvanSix is well positioned to deliver robust performance and returns over the long-term,” concluded Kane.

For earnings history and earnings-related data on AdvanSix (ASIX) click here.